Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Kala Azar”

211 trials

Showing 20 of 211 results

Not applicableUnknownNCT05426577
What this trial is testing

Evaluation of Less Invasive Procedures for Visceral Leishmaniasis Treatment Efficacy Monitoring Test of Cure

Who this might be right for
Visceral Leishmaniasis
Foundation for Innovative New Diagnostics, Switzerland 60
Testing effectiveness (Phase 2)Study completedNCT00233545
What this trial is testing

Miltefosine to Treat Cutaneous Leishmaniasis in Bolivia

Who this might be right for
Cutaneous Leishmaniasis
AB Foundation 80
Post-approval studies (Phase 4)Study completedNCT01032187
What this trial is testing

Amphotericin B to Treat Visceral Leishmaniasis in Brazilian Children

Who this might be right for
Visceral Leishmaniasis
University of Brasilia 101
Not applicableStudy completedNCT03646981
What this trial is testing

Evaluation of Antibody Detection Tests for Visceral Leishmaniasis Diagnosis in Eastern Africa

Who this might be right for
Leishmaniasis, Visceral
Foundation for Innovative New Diagnostics, Switzerland 704
Testing effectiveness (Phase 2)UnknownNCT00537953
What this trial is testing

Short Course of Miltefosine and Antimony to Treat Cutaneous Leishmaniasis in Bolivia

Who this might be right for
Cutaneous Leihmaniasis
Centro de Investigaciones Bioclínicas de la Fundación Fader
Not applicableStudy completedNCT04841239
What this trial is testing

Development of Topical Herbal Formulations for Treatment of Cutaneous Leishmaniasis

Who this might be right for
Leishmaniasis, Cutaneous
Jinnah Sindh Medical University 78
Testing effectiveness (Phase 2)Study completedNCT00373776
What this trial is testing

Miltefosine for Mucosal Leishmaniasis

Who this might be right for
Leishmaniasis
AB Foundation 75
Not applicableStudy completedNCT05449717
What this trial is testing

Incidence of Relapse and Post-Kala-Azar Dermal Leishmaniasis in South Sudan

Who this might be right for
LeishmaniasisLeishmaniasis, VisceralPost-kala-azar Dermal Leishmaniasis
Epicentre 52
Testing effectiveness (Phase 2)Study completedNCT01377974
What this trial is testing

Clinical Trial of Miltefosine to Treat Mucosal Leishmaniasis

Who this might be right for
LeishmaniasisLeishmaniasis, Mucocutaneous
Brasilia University Hospital 40
Early research (Phase 1)Study completedNCT00001906
What this trial is testing

Safety and Immunogenicity of a Vaccine for Cutaneous Leishmaniasis Using Recombinant Human Interleukin-12 and Aluminum Hydroxide Gel as Adjuvants

Who this might be right for
Cutaneous Leishmaniasis
National Institute of Allergy and Infectious Diseases (NIAID) 50
Large-scale testing (Phase 3)Study completedNCT03023111
What this trial is testing

Miltefosine and GM-CSF in Cutaneous Leishmaniasis

Who this might be right for
Cutaneous Leishmaniasis
Hospital Universitário Professor Edgard Santos 300
Not applicableStudy completedNCT01069198
What this trial is testing

A Community Trial for Visceral Leishmaniasis (VL)

Who this might be right for
Visceral Leishmaniasis
International Centre for Diarrhoeal Disease Research, Bangladesh 200
Not applicableUnknownNCT03762070
What this trial is testing

Evaluation of a Diagnostic Device, CL Detect™ Rapid Test, for the Diagnosis of Cutaneous Leishmaniasis in Peru

Who this might be right for
Leishmaniasis, Cutaneous
Naval Medical Research Center 200
Large-scale testing (Phase 3)Study completedNCT03129646
What this trial is testing

Miltefosine/Paromomycin Phase III Trial for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern Africa

Who this might be right for
Visceral Leishmaniasis
Drugs for Neglected Diseases 439
Large-scale testing (Phase 3)Study completedNCT00216346
What this trial is testing

Safety and Efficacy Study of Paromomycin to Treat Visceral Leishmaniasis

Who this might be right for
Visceral Leishmaniasis
PATH 667
Early research (Phase 1)Ended earlyNCT06124144
What this trial is testing

Safety and Drug Absorption of Orally Administered Oleylphosphocholine (OlPC) in Healthy Adults

Who this might be right for
Leishmaniasis
University Hospital Tuebingen 13
Large-scale testing (Phase 3)Study completedNCT00628719
What this trial is testing

Single Infusion of Liposomal Amphotericin B in Indian Visceral Leishmaniasis

Who this might be right for
Visceral Leishmaniasis
Banaras Hindu University 400
Not applicableStudy completedNCT00469495
What this trial is testing

Antihelminthic Therapy Combined With Antimony in the Treatment of Cutaneous Leishmaniasis

Who this might be right for
Leishmaniasis, CutaneousHelminthiasis
Hospital Universitário Professor Edgard Santos 90
Not applicableStudy completedNCT00344084
What this trial is testing

Surveillance for Leishmaniasis Skin Lesions in Mali

Who this might be right for
Cutaneous Leishmaniasis
National Institute of Allergy and Infectious Diseases (NIAID) 1,593
Large-scale testing (Phase 3)Ended earlyNCT00317629
What this trial is testing

Controlled Nitric Oxide Releasing Patch Versus Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis

Who this might be right for
Cutaneous Leishmaniasis
Fundación Cardiovascular de Colombia 178
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation